On June 4, 2018 Checkpoint Therapeutics, Inc. ("Checkpoint") (NASDAQ: CKPT), a clinicalstage, immuno-oncology biopharmaceutical company focused on the acquisition, development andbcommercialization of novel treatments for patients with solid tumor cancers, reported that James F. Oliviero, President and Chief Executive Officer, will participate in two investor conferences in June (Press release, Checkpoint Therapeutics, JUN 4, 2018, View Source [SID1234527113]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
• Jefferies 2018 Global Healthcare Conference on Friday, June 8, 2018, at 10:30 a.m. EDT at the Grand Hyatt in New York City
• JMP Securities Life Sciences Conference on Thursday, June 21, 2018, at 12:30 p.m. EDT at the St. Regis New York in New York City
Live webcasts of the presentations will be available on the Events page of the Investors & Media section
of Checkpoint’s website: www.checkpointtx.com. An archived replay of the webcast will be available for
approximately 30 days following the presentation.